Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Iran to join insulin producers club in four years
TEHRAN — Iran will join the five countries producing insulin once the Pars Novo Nordisk pharmaceutical company comes on stream in the next four years, said the vice president and general manager of ...
Opdivo approved quickly for first hematological cancer
FDA granted accelerated approval to Opdivo nivolumab from Bristol-Myers Squibb Co.
Avanir Announces U.S. Launch And Availability Of ONZETRA Xsail
Avanir Pharmaceuticals, Inc.
Bengt Sjöberg donates SEK 2 billion to cancer research
Bengt Sjöberg, resident in Hong Kong but originally from Lysekil, Sweden, has founded the Sjöberg Foundation, to which he has donated SEK 2 billion.
Pfizer blocks its drugs from use in lethal injections
- Pfizer Inc has taken steps to ensure that none of its products are used in lethal injections, the largest U.
Mylan to Buy Renaissance Skin Drug Unit for About $1 Billion
Mylan NV agreed to buy skin drug assets from Renaissance Acquisition Holdings LLC for about $1 billion to complement its existing products.
Pfizer to Buy Anacor for $4.5 Billion
Pfizer Inc.
Bayer stops riociguat study on safety concerns
Bayer has terminated with immediate effect a mid-stage trial assessing riociguat in pulmonary hypertension associated with idiopathic interstitial pneumonia because of serious safety concerns.
Larry Ellison Gives $200 Million to USC for Cancer Research
Larry Ellison, co-founder of database giant Oracle Corp.
Top health official misled Congress on Obamacare exchange spending, House panel says
A House panel said Tuesday that a top administration health official misled Congress last year by seeming to suggest that the government had already recaptured hundreds of millions of dollars from str...
NICE deems Bristol-Myers' Opdivo too pricey for lung cancer
England’s cost-effectiveness watchdogs are influential arbiters in the drug-reimbursement world.
Baxter close on deal for India's Gland Pharma: Sources
Baxter CEO José Almeida told analysts last month the company was looking for manageable M&A deals and that sterile injectables was an area he is focused on.
623
624
625
626
627
628
629
630
631